CRISPR Therapeutics Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About CRISPR Therapeutics Ltd
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.
/ 
Frequently asked questions
To buy CRISPR Therapeutics Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for CRISPR Therapeutics Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for CRISPR Therapeutics Ltd is CRSP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
CRISPR Therapeutics Ltd has its primary listing on NASDAQ. You can trade CRISPR Therapeutics Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, CRISPR Therapeutics Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include CRISPR Therapeutics Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like CRISPR Therapeutics Ltd.